88
Participants
Start Date
December 22, 2017
Primary Completion Date
July 22, 2020
Study Completion Date
July 22, 2020
IW-1701
Oral Tablet
Placebo
Oral Tablet
Jacobi Medical Center, The Bronx
New York Medical College, Valhalla
University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
The Clinical Trial Center LLC, Jenkintown
MedStar Health Research Institute, MedStar Washington Hospital Center, Washington D.C.
Howard University Center for Sickle Cell Disease, Washington D.C.
University of Maryland Medical Center, Baltimore
Johns Hopkins School of Medicine Children's Center, Baltimore
Virginia Commonwealth University - Clinical Research Unit, Richmond
East Carolina University - Leo W. Jenkins Cancer Center, Greenville
East Carolina University Brody School of Medicine, Department of Pediatrics, Division of Pediatric Hematology, Greenville
Grady Memorial Hospital, Atlanta
Atlanta Center for Medical Research, Atlanta
Century Clinical Research, Inc., Fort Lauderdale
Omega Research Maitland, LLC, Orlando
Foundation for Sickle Cell Disease Research, Hollywood
Children's Hospital of Michigan-Detroit, Detroit
Innovative Medical Research of South Florida, Inc., Aventura
Blood Center of Wisconsin (BCW), Wauwatosa
Healthcare Research Network II, LLC, Flossmoor
University of Illinois at Chicago, Chicago
Healthcare Research Network, Hazelwood
Clinical Trials of SWLA, LLC, Lake Charles
Lynn Institute of Tulsa, Tulsa
"UT Health Clinical Research Unit Center for Clinical and Translational Sciences", Houston
Accurate Clinical Research, Baytown
Mays Cancer Center UT Health San Antonio, San Antonio
Children's Hospital of Orange County, Orange
Boston Children's Hospital, Boston
Hackensack University Medical Center, Pediatric Hematology and Oncology, Hackensack
Hammoud Hospital University Medical Center, Sidon
Nini Hospital, Tripoli
Royal London Hospital, London
Whittington Hospital, London
Guys and St Thomas NHS Foundation Trust - Evelina London Childrens Hospital, London
Guy's Hospital, London
Hammersmith Hospital, London
Lead Sponsor
Cyclerion Therapeutics
INDUSTRY